Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Carcinoma, Hepatocellular 10Liver Neoplasms 8Neoplasm Metastasis 6Colorectal Neoplasms 6Melanoma 4Esophageal Neoplasms 4Sarcoma 3Prostatic Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Carcinoma, Renal Cell 3Rectal Neoplasms 2Pancreatic Neoplasms 2Osteosarcoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Biliary Tract Neoplasms 2Barrett Esophagus 2Wilms Tumor 1Uveal Melanoma 1Unresectable Pancreatic Cancer 1Tongue Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Pancreatic Adenocarcinoma Locally Advanced 1Pain 1

Interventions

X-Rays 4Phantoms, Imaging 4Cyclophosphamide 4fludarabine 3Specimen Handling 3Melphalan 3Magnetic Resonance Spectroscopy 3ulixertinib 2tipifarnib 2tazemetostat 2talazoparib 2selpercatinib 2palbociclib 2ivosidenib 2Vemurafenib 2Temozolomide 2Sirolimus 2Nuclear Medicine Department, Hospital 2Nivolumab 2LY3023414 2Granulocyte Colony-Stimulating Factor 2Busulfan 2regorafenib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1olaparib 1larotrectinib 1irinotecan sucrosofate 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Cryosurgery × Gastrointestinal × Clear all
NCT05302921 2025-01-01

Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors

Children's National Research Institute

Phase 2 Completed
5 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Melanoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡